Media headlines about Allscripts Healthcare Solutions (NASDAQ:MDRX) have been trending somewhat positive recently, according to Accern. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Allscripts Healthcare Solutions earned a coverage optimism score of 0.19 on Accern’s scale. Accern also gave media coverage about the software maker an impact score of 46.1279105486619 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Here are some of the headlines that may have effected Accern Sentiment Analysis’s rankings:

Allscripts Healthcare Solutions (NASDAQ:MDRX) traded down 0.767% on Wednesday, reaching $12.285. The company had a trading volume of 419,437 shares. The company has a 50-day moving average of $12.41 and a 200 day moving average of $12.07. The stock’s market cap is $2.23 billion. Allscripts Healthcare Solutions has a one year low of $9.80 and a one year high of $15.17.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings data on Thursday, May 4th. The software maker reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.01. Allscripts Healthcare Solutions had a positive return on equity of 5.75% and a negative net margin of 2.93%. The company had revenue of $415 million for the quarter, compared to analyst estimates of $415.20 million. During the same period in the prior year, the company posted $0.13 EPS. The company’s revenue was up 20.1% compared to the same quarter last year. On average, equities research analysts predict that Allscripts Healthcare Solutions will post $0.62 EPS for the current year.

A number of equities research analysts have weighed in on MDRX shares. Zacks Investment Research upgraded Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research note on Wednesday, April 19th. Leerink Swann lowered Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and lowered their price objective for the company from $15.00 to $13.00 in a research note on Monday, June 19th. Cantor Fitzgerald restated a “neutral” rating and set a $13.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Monday, May 15th. Maxim Group restated a “buy” rating and set a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Monday, May 15th. Finally, BidaskClub upgraded Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research note on Saturday, June 24th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and ten have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $14.74.

WARNING: This piece was posted by Daily Political and is the property of of Daily Political. If you are reading this piece on another website, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/07/26/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-allscripts-healthcare-solutions-mdrx-share-price.html.

In related news, President Richard J. Poulton sold 25,000 shares of the stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $12.06, for a total transaction of $301,500.00. Following the sale, the president now directly owns 412,488 shares in the company, valued at approximately $4,974,605.28. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.75% of the stock is owned by corporate insiders.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Insider Buying and Selling by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.